EUCTR2004-002020-17-ES进行中（未招募）不适用
ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR).(STRATEGIES FOR THE TREATMENT OF ARTERIAL HYPERTENSION. ASSESSMENT OF A COMBINED THERAPY AT FIXED DOSES (LOSARTAN/HYDROCHOLOTHIAZIDE) vs MONOTHERAPY (ESTRATAAR) - ESTRATAAR
Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel0 个研究点目标入组 140 人开始时间: 2005年12月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients diagnosed of stage II arterial hipertensión (JNC7, BP>160/100), currently without therapy, or under monotherapy al teast 4 weeks who have not reaches BP control.
- •2. For diabetic patients BP to be included will be >150/90.
- •3. White coat hypertension has been excluded (Ambulatory BP Monitorization)
- •4. Informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patient denies to participate.
- •2. Patient is not an adult, of has not a mental condition to understannd protocol procedures and collaborate.
- •3. Non complaints.
- •4. Alcohol or drug abuse.
- •5. Pregnant women or breastfeeding period, or women who foresee to become pregnant
- •6. Secondary hypertension (suspected or confirmed)
- •7. White coat hypertension
- •8. Combined therapy is needed due to patient´s clinical condition.
- •9. Presence of cardiovascular disease.
- •10. Renal damage (Creatinine > 1,2 (women) y 1,5 (men)).
- •11. Liver disease (serum transaminases > 3 times upper limit, or chronic liver disease).
- •12. High serum potassium (>5,5)
- •13. Severe current disease (cancer, degenerative..)
- •14. Patients currently treated and controlled
- •15. Patients not controlled under combination theraphy.
- •16. Very high BP (>200/110)
- •17. Intolerance, allergy or contraindication to study medication (ARB and diuretics)
研究者
相似试验
尚未招募
不适用
Stepwise treatment of uncontrolled high blood pressure in general practiceTherapyresistantUncontrolledHypertensionPrimary Care TherapieresistentOngecontrolleerdHypertensie Eerste lijnNL-OMON22505MC Utrecht240
已完成
不适用
STEPWISE treatment of uncontrolled HyperTensioN in primary care: a cluster randomised trial.NL-OMON50648Julius Centrum240
已完成
不适用
Methods of implementing guidelines for hypertension in primary care: acceptability, effectiveness and cost-effectivenessCardiovascular diseases: HypertensionCirculatory SystemHypertensionISRCTN16617840HS R&D Regional Programme Register - Department of Health (UK)
尚未招募
不适用
Self-care in hypertensioCTRI/2022/03/041383Indian Council of Medical Research
已完成
不适用
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertensionISRCTN55725285Solvay Pharmaceuticals (Germany)